Compare INKT & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INKT | NAMM |
|---|---|---|
| Founded | 2017 | 2024 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.7M | 56.4M |
| IPO Year | 2021 | N/A |
| Metric | INKT | NAMM |
|---|---|---|
| Price | $11.12 | $0.99 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | 21.0K | ★ 151.4K |
| Earning Date | 11-14-2025 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $80,348,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.52 |
| 52 Week Low | $4.56 | $0.96 |
| 52 Week High | $76.00 | $55.00 |
| Indicator | INKT | NAMM |
|---|---|---|
| Relative Strength Index (RSI) | 41.73 | N/A |
| Support Level | $10.84 | N/A |
| Resistance Level | $12.31 | N/A |
| Average True Range (ATR) | 0.61 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 18.14 | 0.00 |
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.